Governance
We have the trust of over a million patients and around 100,000 shareholders and we are committed to operating at the highest standards of corporate governance.
ANNUAL REPORT 2020-2021
The ongoing COVID-19 crisis has thrown up several challenges for businesses globally. For the pharmaceutical sector, these challenges turned out to be volatile and with unprecedented levels of disruption. Companies went the extra mile to ensure that manufacturing and distribution of medicines continued uninterrupted, despite an uncertain and unpredictable operating environment.
At GSK, we are committed to operating at the highest standards of corporate governance.
We believe our governance structure underpins our ability to deliver the company's strategy to grow a diversified business, deliver more products of value and simplify the operating model.
This section provides information on how GSK is governed, including details on our Board Committees, shareholder information and services, global compliance and ethical conduct.
Board Committees and membership
| Audit Committee | |
| D. Sundaram | Chairman |
| Ms. R.S.Karnad | |
| N. Kaviratne | |
| P.V. Bhide | |
| Ajay Nadkarni | Secretary |
| Nomination and Remuneration Committee | |
| N. Kaviratne | Chairman |
| Ms. R.S.Karnad | |
| D. Sundaram | |
| Ajay Nadkarni | Secretary |
| Stakeholder Relationship Committee | |
| Ms. R.S.Karnad | Chairperson |
| P.V. Bhide | |
| S. Venkatesh | |
| Ajay Nadkarni | Secretary |
| Corporate Social Responsibility (CSR) Committee | |
| A. N. Roy | Chairman |
| Dr. S. Maheshwari | |
| S. Venkatesh | |
| Ajay Nadkarni | Secretary |
| Share Transfer Committee | |
| S. Venkatesh | Chairman |
| Ms. P. Thakur | |
| Ajay Nadkarni | Secretary |
| Risk Management Committee | |
| D. Sundaram | Chairman |
| Ms. R.S.Karnad | |
| N. Kaviratne | |
| P.V. Bhide | |
| Ajay Nadkarni | Secretary |